Nikkei 225 · Precision optics (semiconductor lithography, nanoimprint)
Canon
Canon is a precision-optics conglomerate that earns over half its revenue from cameras and office equipment (Printing), but the real re-rating point hides in the 8%-of-sales Industrial unit — the call option on nanoimprint lithography (NIL), regarded as the one path to shrink chips without EUV (ASML). FY2025 consolidated sales of JPY 4,624.7bn (+2.5%) and OP of JPY 455.4bn make for modest top-line growth, but the profit gain is pulled by Imaging (+12.5%) and AI-related lithography while Printing (-1.1%) structurally shrinks. With the NIL it co-developed with Kioxia and DNP over a decade having shipped its first commercial tool (to TIE) in 2024, the question is whether a semiconductor-equipment option is embedded in a stock the market still prices as a declining camera/printer company.
7751.T Updated Jul 12, 2026 3 AI consumers
Per the valuechain.wiki graph, Canon is directly linked to 2 companies (1 supply, 1 revenue relationships) and reaches 6 companies within two hops; the links are backed by 10 dated sources, 3 of them primary filings (as of 2026-07-12).
Financials & Segments
- Total revenue · Sales JPY 4,624.7bn (+2.5%), OP JPY 455.4bn (OPM 9.8%), net profit JPY 332.1bn — a modest top line, with the profit gain pulled by Imaging and AI-driven lithography and dragged by Printing (FY2025 consolidated)
- Customer concentration · The structure is 'a declining cash cow (Printing) funding a growth option (Industrial NIL).' The market prices Canon on camera/printer decline, but the real re-rating axis is whether the NIL it co-developed with Kioxia and DNP over a decade commercializes as a path to shrink that bypasses EUV. FY2025 OP JPY 455.4bn, OPM 9.8%.
- Segments · Printing (53.9%) · Imaging (22.8%) · Medical (12.6%) · Industrial - lithography, NIL (7.8%)
Revenue from
- Semiconductor & FPD makers (i-line/KrF lithography) High confidence
At just 8% of sales, Industrial is where Canon's re-rating option sits — i-line/KrF scanners already earn cash at high share in mature IoT nodes, while FPD lithography leans on Korean panel makers. The real driver of FY2025's +2.7% was AI-related semiconductor investment, and against Nikon and ASML, Canon's hand is not leading-edge EUV but low-cost coverage of the mature and specialty layers beneath it. - Texas Institute for Electronics (TIE) — first commercial NIL High confidence
The first commercial NIL reference — in 2024 Canon shipped an FPA-1200NZ2C to a Texas consortium backed by AMD, Intel, Micron and Applied Materials. What matters is less the revenue than the proof that a real semiconductor ecosystem will take and run it: with 14nm (5nm-node-class) patterning demonstrated, it signals NIL leaving the lab for a commercial trajectory.Confirms EN TrendForce Published Sep 30, 2024: Canon Delivers NIL System to TIE, Reportedly Capable of 2nm ChipsConfirms EN Canon Published Oct 13, 2023: Canon launches the first nanoimprint lithography semiconductor system - Kioxia (NIL co-development, NAND application) Medium confidence
NIL has no commercial future unless a major memory maker qualifies it on a production line — and Kioxia is that anchor customer. In the mutually dependent Canon (tool) / Kioxia (process) / DNP (mask) triangle, the NAND application does not exist without Kioxia. But it is still at tool-test/process-qualification stage, so what this relationship produces today is option value, not cash revenue.Confirms EN IEEE Spectrum Published Mar 1, 2024: Canon Delivers Nanoimprint Lithography to Compete With EUV
Pays to
- Optical glass, aluminum, steel, chemicals (raw materials) High confidence
Canon sources glass, aluminum, steel and chemicals globally while making key parts in-house to control external dependence — raw-material prices (e.g., crude) hit margins directly, but its degree of vertical integration acts as a cost-shock buffer versus peers. - Dai Nippon Printing (NIL masks/templates) Medium confidence
The upstream supplier of masks/templates (masters) in the NIL triangle — however precise Canon's tool, the node stalls if DNP's template shrink (targeting 1.4nm-class by 2027) does not keep pace. Canon's NIL roadmap is therefore chained to DNP's template roadmap: not a rivalry but a shared-fate dependency.Confirms EN IEEE Spectrum Published Mar 1, 2024: Canon Delivers Nanoimprint Lithography to Compete With EUV - Semiconductor chips (external procurement) Medium confidence
Canon buys the chips that go into its cameras, printers and medical devices — a paradox for a company that itself sells semiconductor lithography yet depends on foundries for its own product chips; in a global chip shortage, higher input cost and delivery delays cut straight into sales.
Investments
- Canon Medical Systems (formerly Toshiba Medical Systems) High confidence
The 2016 acquisition of Toshiba Medical for ~JPY 665.5bn was a business investment that bought, whole, a non-imaging growth axis to offset the structural decline of cameras and printers — the result is FY2025 Medical sales of JPY 580.6bn, extended via Redlen (photon-counting CT) and Axis (network video) as Canon redeploys its optics/precision skills into healthcare and security.
Value-chain ripple (2 tiers)
Following node-to-node links up to 2 tiers; each firm is shown once, at its nearest tier.
| Company | Chain | '21 | '22 | '23 | '24 | '25 | YTD |
|---|---|---|---|---|---|---|---|
| Everpure (formerly Pure Storage) | lead2 | +44 | -17.8 | +33.3 | +72.3 | +9.1 | +18.4 |
| NVIDIA | lead2 | +125.5 | -50.3 | +239 | +171.2 | +38.9 | +13.3 |
| Phison Electronics | lead2 | +26.8 | -10.7 | +45.1 | -6.7 | +418.3 | -6 |
| Kioxia | lead1 | · | · | · | · | +1082.1 | +260.5 |
| Canon | node | +22.5 | +11.1 | +46.4 | +27 | -3.2 | -5.6 |
| Dai Nippon Printing | benef1 | +56.5 | +13.9 | +42.6 | +8.5 | +22.5 | +15.3 |
| Hoya Corporation | benef2 | +10.8 | -3 | +34.4 | +11.3 | +24.9 | -2.9 |
YTD as of 2026-07-10 · source: Yahoo Finance
Canon's thesis is 'a cash cow buying an option' — Printing, half of revenue, is in structural decline yet throws off cash, and that cash funds the Industrial NIL semiconductor-equipment option. In FY2025 (sales JPY 4,624.7bn, +2.5%; OP JPY 455.4bn) the profit gain came from Imaging (+12.5%) and AI-related lithography, while the market still prices camera/printer decline. The key variable is NIL's volume adoption: if a major memory maker in the Canon/Kioxia/DNP triangle puts it on an HVM line, Industrial re-rates from a 7.8% niche into a structural semiconductor-equipment story — though defect concerns keep the 'not yet' rebuttal alive. In the graph the ripple runs AI-chip capex → lithography demand → Canon (bypassing Nikon/ASML), with DNP's template shrink as the upstream roadmap bottleneck.
Analysis generated from returns as of 2026-07-10